aluates Reports

$ 0.0

Automative

Global Non-Hodgkin's Lymphoma Drug Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-12F10138

Global Non Hodgkin s Lymphoma Drug Market Insights Forecast to 2028

BUY CHAPTERS

Global Non-Hodgkin's Lymphoma Drug Market Research Report 2025

Code: QYRE-Auto-12F10138

Report

July 2025

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Gilead Sciences

TG Therapeutics

Bayer

Secura Bio

EpiZyme Inc

Eisai Co Ltd

Acrotech Biopharma

TEVA

Eagle Pharmaceuticals

Mundipharma

Non-Hodgkin's Lymphoma Drug Market Size

The global market for Non-Hodgkin's Lymphoma Drug was valued at US$ 8990 million in the year 2024 and is projected to reach a revised size of US$ 14530 million by 2031, growing at a CAGR of 7.2% during the forecast period.

Non-Hodgkin's Lymphoma Drug Market

Non-Hodgkin"s lymphoma is a type of cancer that begins in your lymphatic system, which is part of the body"s germ-fighting immune system. In non-Hodgkin"s lymphoma, white blood cells called lymphocytes grow abnormally and can form growths (tumors) throughout the body.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Non-Hodgkin's Lymphoma Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Hodgkin's Lymphoma Drug.

The Non-Hodgkin's Lymphoma Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-Hodgkin's Lymphoma Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Non-Hodgkin's Lymphoma Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Non-Hodgkin's Lymphoma Drug Market Report

Report Metric	Details
Report Name	Non-Hodgkin's Lymphoma Drug Market
Accounted market size in year	US$ 8990 million
Forecasted market size in 2031	US$ 14530 million
CAGR	7.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Oral Injection
Segment by Application	Hospital Retail Pharmacy Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Gilead Sciences, TG Therapeutics, Bayer, Secura Bio, Epizyme, Eisai, Acrotech Biopharma, Teva, Eagle Pharmaceuticals, MundiPharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-Hodgkin's Lymphoma Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Non-Hodgkin's Lymphoma Drug Market growing?

Ans: The Non-Hodgkin's Lymphoma Drug Market witnessing a CAGR of 7.2% during the forecast period 2025-2031.

What is the Non-Hodgkin's Lymphoma Drug Market size in 2031?

Ans: The Non-Hodgkin's Lymphoma Drug Market size in 2031 will be US$ 14530 million.

Who are the main players in the Non-Hodgkin's Lymphoma Drug Market report?

Ans: The main players in the Non-Hodgkin's Lymphoma Drug Market are Roche, Gilead Sciences, TG Therapeutics, Bayer, Secura Bio, Epizyme, Eisai, Acrotech Biopharma, Teva, Eagle Pharmaceuticals, MundiPharma

What are the Application segmentation covered in the Non-Hodgkin's Lymphoma Drug Market report?

Ans: The Applications covered in the Non-Hodgkin's Lymphoma Drug Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Non-Hodgkin's Lymphoma Drug Market report?

Ans: The Types covered in the Non-Hodgkin's Lymphoma Drug Market report are Oral, Injection

Recommended Reports

Lymphoma Drug Markets

Hematological Malignancies

Cancer Drug Therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-Hodgkin's Lymphoma Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Oral

1.2.3 Injection

1.3 Market by Application

1.3.1 Global Non-Hodgkin's Lymphoma Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Retail Pharmacy

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Non-Hodgkin's Lymphoma Drug Market Perspective (2020-2031)

2.2 Global Non-Hodgkin's Lymphoma Drug Growth Trends by Region

2.2.1 Global Non-Hodgkin's Lymphoma Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Non-Hodgkin's Lymphoma Drug Historic Market Size by Region (2020-2025)

2.2.3 Non-Hodgkin's Lymphoma Drug Forecasted Market Size by Region (2026-2031)

2.3 Non-Hodgkin's Lymphoma Drug Market Dynamics

2.3.1 Non-Hodgkin's Lymphoma Drug Industry Trends

2.3.2 Non-Hodgkin's Lymphoma Drug Market Drivers

2.3.3 Non-Hodgkin's Lymphoma Drug Market Challenges

2.3.4 Non-Hodgkin's Lymphoma Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Non-Hodgkin's Lymphoma Drug Players by Revenue

3.1.1 Global Top Non-Hodgkin's Lymphoma Drug Players by Revenue (2020-2025)

3.1.2 Global Non-Hodgkin's Lymphoma Drug Revenue Market Share by Players (2020-2025)

3.2 Global Non-Hodgkin's Lymphoma Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Non-Hodgkin's Lymphoma Drug Revenue

3.4 Global Non-Hodgkin's Lymphoma Drug Market Concentration Ratio

3.4.1 Global Non-Hodgkin's Lymphoma Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non-Hodgkin's Lymphoma Drug Revenue in 2024

3.5 Global Key Players of Non-Hodgkin's Lymphoma Drug Head office and Area Served

3.6 Global Key Players of Non-Hodgkin's Lymphoma Drug, Product and Application

3.7 Global Key Players of Non-Hodgkin's Lymphoma Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Non-Hodgkin's Lymphoma Drug Breakdown Data by Type

4.1 Global Non-Hodgkin's Lymphoma Drug Historic Market Size by Type (2020-2025)

4.2 Global Non-Hodgkin's Lymphoma Drug Forecasted Market Size by Type (2026-2031)

5 Non-Hodgkin's Lymphoma Drug Breakdown Data by Application

5.1 Global Non-Hodgkin's Lymphoma Drug Historic Market Size by Application (2020-2025)

5.2 Global Non-Hodgkin's Lymphoma Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Non-Hodgkin's Lymphoma Drug Market Size (2020-2031)

6.2 North America Non-Hodgkin's Lymphoma Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Non-Hodgkin's Lymphoma Drug Market Size by Country (2020-2025)

6.4 North America Non-Hodgkin's Lymphoma Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Non-Hodgkin's Lymphoma Drug Market Size (2020-2031)

7.2 Europe Non-Hodgkin's Lymphoma Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Non-Hodgkin's Lymphoma Drug Market Size by Country (2020-2025)

7.4 Europe Non-Hodgkin's Lymphoma Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Non-Hodgkin's Lymphoma Drug Market Size (2020-2031)

8.2 Asia-Pacific Non-Hodgkin's Lymphoma Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Non-Hodgkin's Lymphoma Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Non-Hodgkin's Lymphoma Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Non-Hodgkin's Lymphoma Drug Market Size (2020-2031)

9.2 Latin America Non-Hodgkin's Lymphoma Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Non-Hodgkin's Lymphoma Drug Market Size by Country (2020-2025)

9.4 Latin America Non-Hodgkin's Lymphoma Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Non-Hodgkin's Lymphoma Drug Market Size (2020-2031)

10.2 Middle East & Africa Non-Hodgkin's Lymphoma Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Non-Hodgkin's Lymphoma Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Non-Hodgkin's Lymphoma Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Non-Hodgkin's Lymphoma Drug Introduction

11.1.4 Roche Revenue in Non-Hodgkin's Lymphoma Drug Business (2020-2025)

11.1.5 Roche Recent Development

11.2 Gilead Sciences

11.2.1 Gilead Sciences Company Details

11.2.2 Gilead Sciences Business Overview

11.2.3 Gilead Sciences Non-Hodgkin's Lymphoma Drug Introduction

11.2.4 Gilead Sciences Revenue in Non-Hodgkin's Lymphoma Drug Business (2020-2025)

11.2.5 Gilead Sciences Recent Development

11.3 TG Therapeutics

11.3.1 TG Therapeutics Company Details

11.3.2 TG Therapeutics Business Overview

11.3.3 TG Therapeutics Non-Hodgkin's Lymphoma Drug Introduction

11.3.4 TG Therapeutics Revenue in Non-Hodgkin's Lymphoma Drug Business (2020-2025)

11.3.5 TG Therapeutics Recent Development

11.4 Bayer

11.4.1 Bayer Company Details

11.4.2 Bayer Business Overview

11.4.3 Bayer Non-Hodgkin's Lymphoma Drug Introduction

11.4.4 Bayer Revenue in Non-Hodgkin's Lymphoma Drug Business (2020-2025)

11.4.5 Bayer Recent Development

11.5 Secura Bio

11.5.1 Secura Bio Company Details

11.5.2 Secura Bio Business Overview

11.5.3 Secura Bio Non-Hodgkin's Lymphoma Drug Introduction

11.5.4 Secura Bio Revenue in Non-Hodgkin's Lymphoma Drug Business (2020-2025)

11.5.5 Secura Bio Recent Development

11.6 Epizyme

11.6.1 Epizyme Company Details

11.6.2 Epizyme Business Overview

11.6.3 Epizyme Non-Hodgkin's Lymphoma Drug Introduction

11.6.4 Epizyme Revenue in Non-Hodgkin's Lymphoma Drug Business (2020-2025)

11.6.5 Epizyme Recent Development

11.7 Eisai

11.7.1 Eisai Company Details

11.7.2 Eisai Business Overview

11.7.3 Eisai Non-Hodgkin's Lymphoma Drug Introduction

11.7.4 Eisai Revenue in Non-Hodgkin's Lymphoma Drug Business (2020-2025)

11.7.5 Eisai Recent Development

11.8 Acrotech Biopharma

11.8.1 Acrotech Biopharma Company Details

11.8.2 Acrotech Biopharma Business Overview

11.8.3 Acrotech Biopharma Non-Hodgkin's Lymphoma Drug Introduction

11.8.4 Acrotech Biopharma Revenue in Non-Hodgkin's Lymphoma Drug Business (2020-2025)

11.8.5 Acrotech Biopharma Recent Development

11.9 Teva

11.9.1 Teva Company Details

11.9.2 Teva Business Overview

11.9.3 Teva Non-Hodgkin's Lymphoma Drug Introduction

11.9.4 Teva Revenue in Non-Hodgkin's Lymphoma Drug Business (2020-2025)

11.9.5 Teva Recent Development

11.10 Eagle Pharmaceuticals

11.10.1 Eagle Pharmaceuticals Company Details

11.10.2 Eagle Pharmaceuticals Business Overview

11.10.3 Eagle Pharmaceuticals Non-Hodgkin's Lymphoma Drug Introduction

11.10.4 Eagle Pharmaceuticals Revenue in Non-Hodgkin's Lymphoma Drug Business (2020-2025)

11.10.5 Eagle Pharmaceuticals Recent Development

11.11 MundiPharma

11.11.1 MundiPharma Company Details

11.11.2 MundiPharma Business Overview

11.11.3 MundiPharma Non-Hodgkin's Lymphoma Drug Introduction

11.11.4 MundiPharma Revenue in Non-Hodgkin's Lymphoma Drug Business (2020-2025)

11.11.5 MundiPharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Gilead Sciences

TG Therapeutics

Bayer

Secura Bio

EpiZyme Inc

Eisai Co Ltd

Acrotech Biopharma

TEVA

Eagle Pharmaceuticals

Mundipharma

List of Tables

Table 1. Global Non-Hodgkin's Lymphoma Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Oral

Table 3. Key Players of Injection

Table 4. Global Non-Hodgkin's Lymphoma Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Non-Hodgkin's Lymphoma Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Non-Hodgkin's Lymphoma Drug Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Non-Hodgkin's Lymphoma Drug Market Share by Region (2020-2025)

Table 8. Global Non-Hodgkin's Lymphoma Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Non-Hodgkin's Lymphoma Drug Market Share by Region (2026-2031)

Table 10. Non-Hodgkin's Lymphoma Drug Market Trends

Table 11. Non-Hodgkin's Lymphoma Drug Market Drivers

Table 12. Non-Hodgkin's Lymphoma Drug Market Challenges

Table 13. Non-Hodgkin's Lymphoma Drug Market Restraints

Table 14. Global Non-Hodgkin's Lymphoma Drug Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Non-Hodgkin's Lymphoma Drug Market Share by Players (2020-2025)

Table 16. Global Top Non-Hodgkin's Lymphoma Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Hodgkin's Lymphoma Drug as of 2024)

Table 17. Ranking of Global Top Non-Hodgkin's Lymphoma Drug Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Non-Hodgkin's Lymphoma Drug Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Non-Hodgkin's Lymphoma Drug, Headquarters and Area Served

Table 20. Global Key Players of Non-Hodgkin's Lymphoma Drug, Product and Application

Table 21. Global Key Players of Non-Hodgkin's Lymphoma Drug, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Non-Hodgkin's Lymphoma Drug Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Non-Hodgkin's Lymphoma Drug Revenue Market Share by Type (2020-2025)

Table 25. Global Non-Hodgkin's Lymphoma Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Non-Hodgkin's Lymphoma Drug Revenue Market Share by Type (2026-2031)

Table 27. Global Non-Hodgkin's Lymphoma Drug Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Non-Hodgkin's Lymphoma Drug Revenue Market Share by Application (2020-2025)

Table 29. Global Non-Hodgkin's Lymphoma Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Non-Hodgkin's Lymphoma Drug Revenue Market Share by Application (2026-2031)

Table 31. North America Non-Hodgkin's Lymphoma Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Non-Hodgkin's Lymphoma Drug Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Non-Hodgkin's Lymphoma Drug Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Non-Hodgkin's Lymphoma Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Non-Hodgkin's Lymphoma Drug Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Non-Hodgkin's Lymphoma Drug Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Non-Hodgkin's Lymphoma Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Non-Hodgkin's Lymphoma Drug Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Non-Hodgkin's Lymphoma Drug Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Non-Hodgkin's Lymphoma Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Non-Hodgkin's Lymphoma Drug Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Non-Hodgkin's Lymphoma Drug Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Non-Hodgkin's Lymphoma Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Non-Hodgkin's Lymphoma Drug Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Non-Hodgkin's Lymphoma Drug Market Size by Country (2026-2031) & (US$ Million)

Table 46. Roche Company Details

Table 47. Roche Business Overview

Table 48. Roche Non-Hodgkin's Lymphoma Drug Product

Table 49. Roche Revenue in Non-Hodgkin's Lymphoma Drug Business (2020-2025) & (US$ Million)

Table 50. Roche Recent Development

Table 51. Gilead Sciences Company Details

Table 52. Gilead Sciences Business Overview

Table 53. Gilead Sciences Non-Hodgkin's Lymphoma Drug Product

Table 54. Gilead Sciences Revenue in Non-Hodgkin's Lymphoma Drug Business (2020-2025) & (US$ Million)

Table 55. Gilead Sciences Recent Development

Table 56. TG Therapeutics Company Details

Table 57. TG Therapeutics Business Overview

Table 58. TG Therapeutics Non-Hodgkin's Lymphoma Drug Product

Table 59. TG Therapeutics Revenue in Non-Hodgkin's Lymphoma Drug Business (2020-2025) & (US$ Million)

Table 60. TG Therapeutics Recent Development

Table 61. Bayer Company Details

Table 62. Bayer Business Overview

Table 63. Bayer Non-Hodgkin's Lymphoma Drug Product

Table 64. Bayer Revenue in Non-Hodgkin's Lymphoma Drug Business (2020-2025) & (US$ Million)

Table 65. Bayer Recent Development

Table 66. Secura Bio Company Details

Table 67. Secura Bio Business Overview

Table 68. Secura Bio Non-Hodgkin's Lymphoma Drug Product

Table 69. Secura Bio Revenue in Non-Hodgkin's Lymphoma Drug Business (2020-2025) & (US$ Million)

Table 70. Secura Bio Recent Development

Table 71. Epizyme Company Details

Table 72. Epizyme Business Overview

Table 73. Epizyme Non-Hodgkin's Lymphoma Drug Product

Table 74. Epizyme Revenue in Non-Hodgkin's Lymphoma Drug Business (2020-2025) & (US$ Million)

Table 75. Epizyme Recent Development

Table 76. Eisai Company Details

Table 77. Eisai Business Overview

Table 78. Eisai Non-Hodgkin's Lymphoma Drug Product

Table 79. Eisai Revenue in Non-Hodgkin's Lymphoma Drug Business (2020-2025) & (US$ Million)

Table 80. Eisai Recent Development

Table 81. Acrotech Biopharma Company Details

Table 82. Acrotech Biopharma Business Overview

Table 83. Acrotech Biopharma Non-Hodgkin's Lymphoma Drug Product

Table 84. Acrotech Biopharma Revenue in Non-Hodgkin's Lymphoma Drug Business (2020-2025) & (US$ Million)

Table 85. Acrotech Biopharma Recent Development

Table 86. Teva Company Details

Table 87. Teva Business Overview

Table 88. Teva Non-Hodgkin's Lymphoma Drug Product

Table 89. Teva Revenue in Non-Hodgkin's Lymphoma Drug Business (2020-2025) & (US$ Million)

Table 90. Teva Recent Development

Table 91. Eagle Pharmaceuticals Company Details

Table 92. Eagle Pharmaceuticals Business Overview

Table 93. Eagle Pharmaceuticals Non-Hodgkin's Lymphoma Drug Product

Table 94. Eagle Pharmaceuticals Revenue in Non-Hodgkin's Lymphoma Drug Business (2020-2025) & (US$ Million)

Table 95. Eagle Pharmaceuticals Recent Development

Table 96. MundiPharma Company Details

Table 97. MundiPharma Business Overview

Table 98. MundiPharma Non-Hodgkin's Lymphoma Drug Product

Table 99. MundiPharma Revenue in Non-Hodgkin's Lymphoma Drug Business (2020-2025) & (US$ Million)

Table 100. MundiPharma Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

Table 104. Authors List of This Report

List of Figures

Figure 1. Non-Hodgkin's Lymphoma Drug Picture

Figure 2. Global Non-Hodgkin's Lymphoma Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Non-Hodgkin's Lymphoma Drug Market Share by Type: 2024 VS 2031

Figure 4. Oral Features

Figure 5. Injection Features

Figure 6. Global Non-Hodgkin's Lymphoma Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Non-Hodgkin's Lymphoma Drug Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Retail Pharmacy Case Studies

Figure 10. Other Case Studies

Figure 11. Non-Hodgkin's Lymphoma Drug Report Years Considered

Figure 12. Global Non-Hodgkin's Lymphoma Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Non-Hodgkin's Lymphoma Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Non-Hodgkin's Lymphoma Drug Market Share by Region: 2024 VS 2031

Figure 15. Global Non-Hodgkin's Lymphoma Drug Market Share by Players in 2024

Figure 16. Global Top Non-Hodgkin's Lymphoma Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Hodgkin's Lymphoma Drug as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Non-Hodgkin's Lymphoma Drug Revenue in 2024

Figure 18. North America Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Non-Hodgkin's Lymphoma Drug Market Share by Country (2020-2031)

Figure 20. United States Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Non-Hodgkin's Lymphoma Drug Market Share by Country (2020-2031)

Figure 24. Germany Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Non-Hodgkin's Lymphoma Drug Market Share by Region (2020-2031)

Figure 32. China Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Non-Hodgkin's Lymphoma Drug Market Share by Country (2020-2031)

Figure 40. Mexico Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Non-Hodgkin's Lymphoma Drug Market Share by Country (2020-2031)

Figure 44. Turkey Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Non-Hodgkin's Lymphoma Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Roche Revenue Growth Rate in Non-Hodgkin's Lymphoma Drug Business (2020-2025)

Figure 48. Gilead Sciences Revenue Growth Rate in Non-Hodgkin's Lymphoma Drug Business (2020-2025)

Figure 49. TG Therapeutics Revenue Growth Rate in Non-Hodgkin's Lymphoma Drug Business (2020-2025)

Figure 50. Bayer Revenue Growth Rate in Non-Hodgkin's Lymphoma Drug Business (2020-2025)

Figure 51. Secura Bio Revenue Growth Rate in Non-Hodgkin's Lymphoma Drug Business (2020-2025)

Figure 52. Epizyme Revenue Growth Rate in Non-Hodgkin's Lymphoma Drug Business (2020-2025)

Figure 53. Eisai Revenue Growth Rate in Non-Hodgkin's Lymphoma Drug Business (2020-2025)

Figure 54. Acrotech Biopharma Revenue Growth Rate in Non-Hodgkin's Lymphoma Drug Business (2020-2025)

Figure 55. Teva Revenue Growth Rate in Non-Hodgkin's Lymphoma Drug Business (2020-2025)

Figure 56. Eagle Pharmaceuticals Revenue Growth Rate in Non-Hodgkin's Lymphoma Drug Business (2020-2025)

Figure 57. MundiPharma Revenue Growth Rate in Non-Hodgkin's Lymphoma Drug Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Non Hodgkin Lymphoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lymphoma Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non Hodgkin s Lymphoma and Chronic Lymphoma Treatment Market Research Report 2024

Global Follicular Lymphoma Drugs Market Research Report 2025

Global Non Hematological Cancers Market Research Report 2024

Global Follicular Lymphoma Treatment Market Research Report 2025

Global Non Hematological Cancer Treatment Market Research Report 2024

Lymphoblastic Lymphoma Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non Hodgkin Lymphoma Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hodgkin s Lymphoma Drugs Market Research Report 2024

Global Hematological Cancers Market Research Report 2024

Global Non small Cell Lung Cancer Drugs Market Insights Forecast to 2030

Global Blood Tumor Drugs Market Research Report 2024

B Cell Non Hodgkin s Lymphoma NHL Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Blood Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non Melanoma Skin Cancer Market Research Report 2024

Global Blood Tumor Treatment Market Research Report 2024

Global Non Melanoma Skin Cancer Treatment Market Research Report 2024

Hematologic Malignancies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions